Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-24

Clinical Trial Update: Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing liraglutide with glimepiride for blood sugar control in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amaryl (glimepiride)
  • Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED